Avant Technologies and Austrianova launch joint venture Klothonova and its groundbreaking Klotho development programme
Using Austrianova's cell-encapsulation technology, the duo aim to engineer a genetically modified cell line that overexpresses the 'longevity protein' Klotho, paving the way for innovative cell-based therapies to combat age-related diseases